Multiple buying at TerrAscend (:TER)

Jason Wild, a Director and 10% Holder, acquired 35,157 Common Shares on a control or direction basis for registered holder Howard Wild 2012 Grandchildren's Trust, 130,890 Common Shares on a control or direction basis for registered holder Insight Wellness, 850,790 Common Shares on a control or direction basis for registered holder JW Growth Fund, LLC, 1,963,351 Common Shares on a control or direction basis for registered holder JW Opportunities Master Fund, Ltd. and 255,359 Common Shares on a control or direction basis for registered holder JW Partners, LP at a price of $7.640 through a prospectus or prospectus exempt offering on May 27th, 2019. This represents a $24,719,579 investment into the company's shares and an account share holdings change of greater than 100%.

In addition, Michael Nashat, a Senior Officer, Director and 10% Holder, acquired 8,850 Common Shares on a direct ownership basis. This represents a $67,614 investment into the company's shares and an account share holdings change of greater than 100%. Finally, Adam Kozak, a Senior Officer, acquired 4,000 Common Shares on a direct ownership basis. This represents a $30,560 investment into the company's shares and an account share holdings change of greater than 100%.

TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Terrascend Corp is a Canada-based cannabis company. The Company strives to create and deliver products and services that meet the evolving needs of the medical market. The Company provides support to patients through its subsidiaries, Solace Health Inc, a Licensed Producer of medical cannabis, TerraHealth Network Inc, a clinical support program and education platform led by health care professionals, and SolaceRx, a proposed Drug Preparation Premises for the compounding of non-cannabis formulations for a variety of institutions. The Company is owner of a brand Knuba Naturals, which is is a line of cannabis products.